2023 ASCO Genitourinary Cancers Symposium - (formerly 2023 Genitourinary Cancers Symposium)
Key Metrics
-
Attendees
- -
Exhibitors
verified -
Register
Why Attend
Overview
The ASCO Genitourinary Cancers Symposium is a premier conference for Genitourinary oncologists.
Why Attend – 2023
The Symposium is a three-day scientific and educational meeting designed to provide attendees with in-depth, multidisciplinary analysis of the most timely topics in the study, diagnosis, and treatment of GU malignancies. All members of the cancer care and research community, including medical oncologists, surgical oncologists, radiation oncologists, physicians, nurses and others, will benefit from the Symposium’s exploration of the latest science in the field and its clinical application.
The meeting offers new, innovative findings in GU cancer treatment, research, and care. Attendees also get a chance to earn Continuing Education (CE) credits.
The Industry Expert Theater (IET) brings together industry leaders and attendees for 45-minute, non-accredited educational presentations on the latest in oncology practices, products, services, and technologies.
Why Exhibit – 2023
Exhibitors will get an opportunity to showcase their products and services face to face to a target audience.
Organizer
Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.
ASCO’s mission is conquering cancer through research, education, and promotion of the highest quality, equitable patient care.
Source: Event Website
Source : Event Website
Request Information
Contact
Future and Past Event Dates
More Cancer & Oncology Events
Advanced Therapies Week 2023 (Formerly known as Phacilitate Leaders World)
Jan 17, 2023
Miami Beach, Florida
2023 ASCO Genitourinary Cancers Symposium - (formerly 2023 Genitourinary Cancers Symposium)
Feb 16, 2023
San Francisco, California
49th ACCC 2023 Annual Meeting & Cancer Center Business Summit - Association of Community Cancer Centers
Mar 08, 2023
Washington, District of Columbia